MET Stock Analysis: Buy, Sell, or Hold?
MET - MetLife, Inc.
$78.88
0.65 (0.83%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 04, 2026
3d
Get Alerted When MET Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MET this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MET shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: MET shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$117.94
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$73.23
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MET is currently trading at $78.88, which is considered fair relative to its 30-day fair value range of $76.85 to $80.51. The stock's valuation (Forward PE: 7.9) is in line with its historical norms (7.9). At these levels, the market is pricing in 0.2% annual earnings growth.
Technical Outlook: Technically, MET is in a downtrend. The price is approaching resistance at $78.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MET has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $92.00 (+17.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MET is in a downtrend. The price is approaching resistance at $78.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MET has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $92.00 (+17.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$76.85 -
$80.51
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($92.00)
- BULLISH: Expecting earnings turnaround to 0.2% growth with -5.9% revenue growth
Fair Price Analysis
30-Day Fair Range
$76.85 -
$80.51
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$74.88
Resistance Level
$78.25
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
7.93
Wall Street Target
$92.00
(+17.6%)
Revenue Growth (YoY)
-5.9%
Earnings Growth (YoY)
-32.6%
Profit Margin
5.3%
Valuation Premium vs History
+0.2% premium
PE vs Historical
7.9 vs 7.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.2%
(market-implied from PE analysis)
1-Year Target
$78.39
(+0%)
2-Year Target
$78.54
(+0%)
3-Year Target
$78.70
(+1%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
PE COMPRESSION
$78.37
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 13.4%)
$321.06
(+310%)
Base:
(SPY PE: 7.9, Growth: 13.4%)
$114.22
(+46%)
Bear:
(PE: 6.7, Growth: 13.4%)
$97.09
(+24%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 14.36 | Current EPS (TTM): $5.31
Bull Case
$155.78
(+98%)
Analyst growth 85.7%, PE expands to 15.8
Base Case
$141.61
(+80%)
Market implied 85.7%, PE stable at 14.4
Bear Case
$51.86
(-34%)
Severe decline -20.0%, PE contracts to 12.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 2:59 PM ET
Data refreshes hourly during market hours. Next update: 3:59 PM
Data refreshes hourly during market hours. Next update: 3:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MET showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2025-09-29
Ro Khanna
SELL
2025-08-26
Gilbert Ray Cisneros, Jr.
SELL
2025-08-06
Featured in Portfolios
MET is a key holding in these high-performance investment strategies.
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$32 | 66 BUY |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 58 HOLD |
|
UNM
Unum Group |
BUY
12 analysts |
$96 | 50 HOLD |
|
GL
Globe Life Inc |
BUY
10 analysts |
$169 | 60 HOLD |
|
AFL
Aflac Incorporated |
SELL
13 analysts |
$111 | 66 BUY |
Advanced MET Option Strategies
Professional options setups generated by AI based on today's MET price and gamma walls.
